Louisiana sweet potato growers see success while Mississippi producers face significant weather-related crop losses this ...
Evotec SE announced that Bayer has initiated a Phase 2 clinical study for BAY 3401016, a Semaphorin-3A-targeting monoclonal antibody being developed as a potential therapeutic option for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback